{"id":70738,"date":"2026-09-21T14:10:00","date_gmt":"2026-09-21T07:10:00","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=70738"},"modified":"2026-09-21T14:10:00","modified_gmt":"2026-09-21T07:10:00","slug":"neuralli-mp-goes-global-us-probiotic-medical-food-meets-singapore-hsa-notification","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=70738","title":{"rendered":"Neuralli\u2122 MP Goes Global: US Probiotic Medical Food Meets Singapore HSA Notification"},"content":{"rendered":"\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Milestone Builds on Hong Kong’s Healthcare Professionals Choice Probiotic Award and Full US HSA\/FSA Payment Eligibility<\/span><\/i><\/p>\n

SINGAPORE<\/span>, Sept. 21, 2026<\/span> \/PRNewswire\/ — Bened Life, the leader in psychobiotics, has completed voluntary notification for its flagship product, Neuralli\u2122 MP, with Singapore’s Health Sciences Authority<\/a> (HSA) under the Health Supplements framework (Notification No.: VNS-2026-08-00377) \u2014 reflecting the product’s continued alignment with local regulatory standards. The milestone marks the latest step in Bened Life’s expanding presence across the APAC region.<\/p>\n

\n

\"\"<\/a>
<\/span><\/p>\n<\/div>\n

Under this framework, Neuralli\u2122 MP has been notified for the general healthy population in accordance with the following health claims from HSA’s List of Health Claims for Health Supplements:<\/p>\n

–\u00a0 Mental Performance:<\/b> Contributes to normal mental performance (S\/N 527)
–\u00a0 Emotional Wellbeing:<\/b> Helps maintain \/ support emotional wellbeing (S\/N 544)
–\u00a0 Sleep Support:<\/b> Helps decrease\/reduce\/relieve disturbed\/restless sleep (S\/N 532)
–\u00a0 Stress Management:<\/b> Supports healthy body stress recovery (S\/N 568)<\/p>\n

These notified claims are backed by PS128\u2122 strain (Lactiplantibacillus plantarum <\/i>\u00a0PS128\u2122), a probiotic strain extensively studied for its role in the gut-brain connection. PS128\u2122 is a novel psychobiotic that appears to balance the “happy hormones” serotonin and dopamine, the “stress hormone” cortisol, and other molecules that affect neurological health, mood, stress response, and focus. Backed by more than\u00a0<\/a>18 clinical studies<\/a>, PS128\u2122 continues to be studied for how it may support this connection between gut health and overall wellbeing.<\/p>\n

The Singapore milestone builds on recent momentum in Hong Kong, where Neuralli\u2122 MP won two major industry honors in as many years: the Healthcare Professional Choice Probiotic Award<\/a> in 2026, voted on directly by the medical community, and the Best Psychobiotic Brand of the Year<\/a> award in 2025. A survey by the Health Research Centre among Hong Kong healthcare professionals found that after one month of using Neuralli\u2122 MP:<\/p>\n